Drug interactions
Argatroban + Caplacizumab
Severity: Major
Argatroban and Caplacizumab: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Caplacizumab inhibits von Willebrand factor-mediated platelet adhesion and argatroban inhibits thrombin, so the combination increases the risk of bleeding.
What this interaction means in plain words
Argatroban and Caplacizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Argatroban belongs to Cardiovascular; Caplacizumab belongs to Cardiovascular.
Why it happens
Additive pharmacodynamic effect on hemostasis through antiplatelet adhesion and anticoagulant actions.
What to do
Avoid the combination unless benefit outweighs risk. If it is used, monitor aPTT and closely watch for bleeding, and consider holding caplacizumab if serious bleeding occurs.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Argatroban and Caplacizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Argatroban
- Argatroban + Defibrotide Contraindicated
- Argatroban + Ketorolac Contraindicated
- Argatroban + Mifepristone Contraindicated
- Abciximab + Argatroban Major
- Acalabrutinib + Argatroban Major
- Acetylsalicylic acid + Argatroban Major
Other interactions of Caplacizumab
Frequently asked questions
Can I take Argatroban with Caplacizumab?
MediHelp rates the interaction as major. Argatroban and Caplacizumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Caplacizumab inhibits von Willebrand factor-mediated platelet adhesion and argatroban inhibits thrombin, so the combination increases the risk of bleeding.
How serious is the interaction between Argatroban and Caplacizumab?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination unless benefit outweighs risk. If it is used, monitor aPTT and closely watch for bleeding, and consider holding caplacizumab if serious bleeding occurs.
What other medicines interact with Argatroban?
MediHelp also lists interactions of Argatroban with, for example, Defibrotide, Ketorolac, Mifepristone. The full list is on the Argatroban page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
